Abhishek A. Solanki, MD, is an Associate Professor of Radiation Oncology at Loyola University Chicago and Edwards Hines Jr., VA Hospital. He completed medical school and radiation oncology residency at the University of Chicago. He is currently the Director of Clinical Research, Director of Quality and Safety, and Chief of the Genitourinary Radiotherapy Service in the Department of Radiation Oncology at Loyola University Chicago. His clinical and research interests include the treatment of newly diagnosed and radio recurrent prostate cancer with image-guided brachytherapy, the use of novel imaging approaches in the management of newly diagnosed, recurrent, and oligometastatic prostate cancer, and the optimization of bladder cancer trimodality therapy. Ronald C Chen, MD MPH, is Brandmeyer Endowed Professor and Chair of Radiation Oncology at the University of Kansas Medical Center, and Associate Director for Health Equity at the University of Kansas Cancer Center. He completed medical school, radiation oncology residency and a Master of Public Health degree at Harvard. Dr. Chen has helped author several prostate cancer clinical practice guidelines for the American Society of Clinical Oncology and the American Urological Association.

Select Guide Rating

• Section 1: Prostate Cancer.- 1. The Management of Prostate Cancer.- 2. Imaging in Prostate Cancer.- 3. Androgen Deprivation Therapy.- 4. Conventional and Moderately Hypofractionated External Beam Radiotherapy.- 5. Low Dose Rate Prostate Brachytherapy.- 6. High Dose Rate Prostate Brachytherapy.- 7. Ultra-hypofractionated Radiotherapy (Stereotactic Body Radiotherapy).- 8. Proton Therapy.- 9. Post-prostatectomy Radiotherapy.- 10. Role of RT in the setting of Metastatic Disease.- Section 2: Non-prostate Genitourinary Malignancies.- 11. Bladder Cancer Radiotherapy.- 12. Testicular Cancer Radiotherapy.- 13. Renal Cell Carcinoma Radiotherapy.- 14.Radiotherapy for Rare GU malignancies (including Penile, Urethral, ureteral/renal pelvis).

Abhishek A. Solanki, MD, is an Associate Professor of Radiation Oncology at Loyola University Chicago and Edwards Hines Jr., VA Hospital. He completed medical school and radiation oncology residency at the University of Chicago. He is currently the Director of Clinical Research, Director of Quality and Safety, and Chief of the Genitourinary Radiotherapy Service in the Department of Radiation Oncology at Loyola University Chicago. His clinical and research interests include the treatment of newly diagnosed and radio recurrent prostate cancer with image-guided brachytherapy, the use of novel imaging approaches in the management of newly diagnosed, recurrent, and oligometastatic prostate cancer, and the optimization of bladder cancer trimodality therapy. Ronald C Chen, MD MPH, is Brandmeyer Endowed Professor and Chair of Radiation Oncology at the University of Kansas Medical Center, and Associate Director for Health Equity at the University of Kansas Cancer Center. He completed medical school, radiation oncology residency and a Master of Public Health degree at Harvard. Dr. Chen has helped author several prostate cancer clinical practice guidelines for the American Society of Clinical Oncology and the American Urological Association.

Select Guide Rating

• Section 1: Prostate Cancer.- 1. The Management of Prostate Cancer.- 2. Imaging in Prostate Cancer.- 3. Androgen Deprivation Therapy.- 4. Conventional and Moderately Hypofractionated External Beam Radiotherapy.- 5. Low Dose Rate Prostate Brachytherapy.- 6. High Dose Rate Prostate Brachytherapy.- 7. Ultra-hypofractionated Radiotherapy (Stereotactic Body Radiotherapy).- 8. Proton Therapy.- 9. Post-prostatectomy Radiotherapy.- 10. Role of RT in the setting of Metastatic Disease.- Section 2: Non-prostate Genitourinary Malignancies.- 11. Bladder Cancer Radiotherapy.- 12. Testicular Cancer Radiotherapy.- 13. Renal Cell Carcinoma Radiotherapy.- 14.Radiotherapy for Rare GU malignancies (including Penile, Urethral, ureteral/renal pelvis).

Abhishek A. Solanki, MD, is an Associate Professor of Radiation Oncology at Loyola University Chicago and Edwards Hines Jr., VA Hospital. He completed medical school and radiation oncology residency at the University of Chicago. He is currently the Director of Clinical Research, Director of Quality and Safety, and Chief of the Genitourinary Radiotherapy Service in the Department of Radiation Oncology at Loyola University Chicago. His clinical and research interests include the treatment of newly diagnosed and radio recurrent prostate cancer with image-guided brachytherapy, the use of novel imaging approaches in the management of newly diagnosed, recurrent, and oligometastatic prostate cancer, and the optimization of bladder cancer trimodality therapy. Ronald C Chen, MD MPH, is Brandmeyer Endowed Professor and Chair of Radiation Oncology at the University of Kansas Medical Center, and Associate Director for Health Equity at the University of Kansas Cancer Center. He completed medical school, radiation oncology residency and a Master of Public Health degree at Harvard. Dr. Chen has helped author several prostate cancer clinical practice guidelines for the American Society of Clinical Oncology and the American Urological Association.

Select Guide Rating

• Section 1: Prostate Cancer.- 1. The Management of Prostate Cancer.- 2. Imaging in Prostate Cancer.- 3. Androgen Deprivation Therapy.- 4. Conventional and Moderately Hypofractionated External Beam Radiotherapy.- 5. Low Dose Rate Prostate Brachytherapy.- 6. High Dose Rate Prostate Brachytherapy.- 7. Ultra-hypofractionated Radiotherapy (Stereotactic Body Radiotherapy).- 8. Proton Therapy.- 9. Post-prostatectomy Radiotherapy.- 10. Role of RT in the setting of Metastatic Disease.- Section 2: Non-prostate Genitourinary Malignancies.- 11. Bladder Cancer Radiotherapy.- 12. Testicular Cancer Radiotherapy.- 13. Renal Cell Carcinoma Radiotherapy.- 14.Radiotherapy for Rare GU malignancies (including Penile, Urethral, ureteral/renal pelvis).